Cargando…

Severe COVID-19 as a virus-independent immunothrombotic process

Detalles Bibliográficos
Autores principales:	Cherian, Robin, Tung, Moon Ley, Chandra, Bharatendu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871659/ https://www.ncbi.nlm.nih.gov/pubmed/35233540 http://dx.doi.org/10.1016/S2665-9913(22)00033-9

Ejemplares similares

Severe COVID-19 as a virus-independent immunothrombotic process – Authors' reply
por: McGonagle, Dennis, et al.
Publicado: (2022)

Positive Bubble Study in Severe COVID-19 Indicates the Development of Anatomical Intrapulmonary Shunts in Response to Microvascular Occlusion
por: Cherian, Robin, et al.
Publicado: (2021)

Anti-phospholipid syndrome and COVID-19 thrombosis: connecting the dots
por: Tung, Moon Ley, et al.
Publicado: (2021)

COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness
por: Cherian, Robin, et al.
Publicado: (2020)

Time to move away from an oxygen-centric model of pulmonary infarction?
por: Cherian, Robin, et al.
Publicado: (2021)

Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy
por: Nicolai, Leo, et al.
Publicado: (2020)

Immunothrombotic dysregulation in chagas disease and COVID-19: a comparative study of anticoagulation
por: Pérez-Campos Mayoral, Laura, et al.
Publicado: (2021)

Vitronectin promotes immunothrombotic dysregulation in the venular microvasculature
por: Uhl, Bernd, et al.
Publicado: (2023)

Re: “Immunothrombotic dysregulation in chagas disease and COVID‑19: a comparative study of anticoagulation”
por: Hasslocher-Moreno, Alejandro Marcel
Publicado: (2022)

Rethinking COVID-19 ‘pneumonia’ – is this primarily a vaso-occlusive disease, and can early anticoagulation save the ventilator famine?
por: Low, Ting-Ting, et al.
Publicado: (2020)

Re. Re.: “Immunothrombotic dysregulation in Chagas disease and COVID19: a comparative study of anticoagulation”
por: Pérez-Campos Mayoral, Laura, et al.
Publicado: (2022)

Endothelial, Immunothrombotic, and Inflammatory Biomarkers in the Risk of Mortality in Critically Ill COVID-19 Patients: The Role of Dexamethasone
por: Keskinidou, Chrysi, et al.
Publicado: (2021)

Co-occurrence of VHL and SDHA Pathogenic Variants: A Case Report
por: Tung, Moon Ley, et al.
Publicado: (2022)

VWF/ADAMTS13 Ratios Are Potential Markers of Immunothrombotic Complications in Patients with COVID-19: A Cross-Sectional Study
por: Madeeva, Daria V, et al.
Publicado: (2020)

Insights Into Immunothrombotic Mechanisms in Acute Stroke due to Vaccine-Induced Immune Thrombotic Thrombocytopenia
por: de Buhr, Nicole, et al.
Publicado: (2022)

Immunothrombotic Mechanisms Induced by Ingenol Mebutate Lead to Rapid Necrosis and Clearance of Anogenital Warts
por: Braun, Stephan A., et al.
Publicado: (2022)

A severe-type COVID-19 case with prolonged virus shedding
por: Liu, Yijie, et al.
Publicado: (2020)

Sustained and intermittent hypoxia differentially modulate primary monocyte immunothrombotic responses to IL-1β stimulation
por: Wahlund, Casper J.E., et al.
Publicado: (2023)

Does MAFLD really increase the severity of COVID-19?
por: Fajar, Jonny Karunia, et al.
Publicado: (2021)

Violations of independence: ethnicity and COVID-19 in Brazil
por: Oreskovic, Tin
Publicado: (2020)

HBV/HCV Infection Was Not Significantly Independently Associated with COVID-19 Severity: A Meta-Analysis of Confounding Variables-Adjusted Data
por: Xu, Jie, et al.
Publicado: (2022)

The need for an independent evaluation of the COVID-19 response in Spain
por: García-Basteiro, Alberto, et al.
Publicado: (2020)

Immunothrombotic Activity of Damage-Associated Molecular Patterns and Extracellular Vesicles in Secondary Organ Failure Induced by Trauma and Sterile Insults
por: Eppensteiner, John, et al.
Publicado: (2018)

Respiratory virus detection among the overseas returnees during the early phase of COVID-19 pandemic in India
por: Potdar, Varsha, et al.
Publicado: (2020)

Polymorphisms and Severity of COVID-19
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Mavrilimumab for severe COVID-19
por: Khan, Adil Rashid, et al.
Publicado: (2020)

Mavrilimumab for severe COVID-19
por: Pourhoseingholi, Mohamad Amin, et al.
Publicado: (2020)

Ruxolitinib and Severe COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Hypertension and severe COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2023)

Severe COVID-19 in an Infant with Severe Acute Malnutrition
por: Beniwal, Neetu, et al.
Publicado: (2021)

The Independent Effect of COVID-19 Vaccinations and Air Pollution Exposure on Risk of COVID-19 Hospitalizations in Southern California
por: Chen, Zhanghua, et al.
Publicado: (2022)

Genetic characterization of dengue virus types 1 and 2 in India, with emphasis on the viruses circulating in Karnataka
por: Yergolkar, Prasanna N., et al.
Publicado: (2017)

Tocilizumab for severe COVID-19 pneumonia
por: Mourad, Jean-Jacques, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Lipworth, Brian J, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Piano, Salvatore, et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19
por: Laine, Marc, et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19
por: Khan, Adil Rashid, et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19
por: Khan, Naim Akhtar
Publicado: (2020)

Reply to: Hypertension and severe COVID-19
por: Shibata, Shigeru, et al.
Publicado: (2023)

Propofol infusion syndrome in severe COVID-19
por: Lucchetta, Vittorio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0su0hvrhaso8jj8m6fvkn9m5s7